The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
How Will The Market Size Of The Anti-Inflammatory Therapeutics Market Evolve From 2026 To 2030?
The anti-inflammatory therapeutics market has seen steady growth in recent years. It is anticipated to expand from $117.28 billion in 2025 to $122.27 billion in 2026, with a compound annual growth rate (CAGR) of 4.3%. This historical expansion can be attributed to the increasing prevalence of arthritis, a rise in inflammatory bowel disease cases, the development of hospital pharmacy networks, the adoption of corticosteroids, and the demand for pain management drugs.
The anti-inflammatory therapeutics market size is anticipated to experience substantial expansion over the coming years. This market is projected to reach $152.04 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.6%. Several factors will contribute to this growth during the forecast period, including the development of targeted biologics, the integration of AI in drug discovery, the expansion of online pharmacies, an increasing geriatric population, and a rising focus on personalized medicine. Key trends anticipated during this period encompass personalized anti-inflammatory treatments, a greater reliance on biologic drugs, the advent of minimally invasive drug delivery methods, an increase in chronic pain management solutions, and the broadening of online pharmacy distribution channels.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12861&type=smp
Which Growth Drivers Are Contributing To The Progress Of The Anti-Inflammatory Therapeutics Market?
The anti-inflammatory therapeutics market is poised for growth due to the escalating incidence of inflammatory bowel disease. This chronic ailment, known as inflammatory bowel disease (IBD), leads to inflammation within the gastrointestinal tract. Anti-inflammatory therapeutics play a critical role in managing Crohn’s disease by mitigating inflammation, alleviating disease symptoms, and decreasing the likelihood of surgical intervention. For illustration, data from Crohn’s and Colitis Canada, a non-profit organization based in Canada, indicated in June 2023 that Canada is expected to have 470,000 individuals suffering from inflammatory bowel disease (IBD) by 2035, a rise from an estimated 322,600 in 2023. Consequently, the expanding occurrence of inflammatory bowel disease is a key factor driving the progress of the anti-inflammatory therapeutics market.
Which Segment Areas Are Covered In The Anti-Inflammatory Therapeutics Market Analysis?
The anti-inflammatory therapeutics market covered in this report is segmented –
1) By Drug Class: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Anti-Inflammatory Biologics
2) By Indication: Arthritis, Respiratory Diseases, Multiple Sclerosis, Psoriasis, Inflammatory Bowel Diseases, Other Inflammatory Diseases
3) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies
Subsegments:
1) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Ibuprofen, Aspirin, Naproxen, Diclofenac, Celecoxib, Indomethacin, Ketoprofen
2) By Corticosteroids: Prednisone, Dexamethasone, Hydrocortisone, Methylprednisolone, Triamcinolone, Betamethasone
3) By Anti-Inflammatory Biologics: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin Inhibitors, Monoclonal Antibodies, Recombinant Proteins, Fusion Proteins
What Key Developments And Trends Are Impacting The Anti-Inflammatory Therapeutics Market?
Leading companies within the anti-inflammatory therapeutics market are concentrating on developing groundbreaking biologic therapies to enhance treatment outcomes for individuals suffering from chronic inflammatory conditions. These advanced treatments are designed to provide targeted immune modulation, superior efficacy, and improved tolerability compared to traditional options such as corticosteroids. For instance, in February 2023, Regeneron Pharmaceuticals Inc., a US-based biotechnology company, and Sanofi, a France-based pharmaceutical and healthcare company, introduced Kevzara (sarilumab), which is the first and only anti-inflammatory biologic recommended for adult patients with polymyalgia rheumatica (PMR) who either do not respond sufficiently to corticosteroids or cannot tolerate corticosteroid tapering. This novel IL-6 receptor inhibitor offers a more effective and steroid-sparing therapeutic choice, addressing a significant unmet need in PMR management and reinforcing the companies’ presence in the anti-inflammatory therapeutics market.
Which Global Companies Are Actively Competing In The Anti-Inflammatory Therapeutics Market?
Major companies operating in the anti-inflammatory therapeutics market are Pfizer Inc., Johnson and Johnson Limited, F. Hoffmann-La Roche Ltd., Merck and Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi-Aventis LLC, Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Co. Ltd., Amgen Inc., Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Biogen Inc., Sun Pharmaceutical Industries Limited, Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals PLC, Cipla Inc., Zydus Lifesciences Ltd., Lupin Limited, Torrent Pharmaceuticals Ltd.
Read the full anti-inflammatory therapeutics market report here:
What Are The Leading Geographic Regions In The Anti-Inflammatory Therapeutics Market?
North America was the largest region in the anti-inflammatory therapeutics market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the anti-inflammatory therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Anti-Inflammatory Therapeutics Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=12861&type=smp
Browse Through More Reports Similar to the Global Anti-Inflammatory Therapeutics Market 2026, By The Business Research Company
Anti Inflammatory Therapeutics Market Report 2026
Non Steroidal Anti Inflammatory Drugs Market Report 2026
Rare Inflammatory Disease Treatment Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model